Rejuvitas, Inc. — Form D
Rejuvitas, Inc. of New York, NY, a company, filed a Form D exempt-offering notice with the SEC on 2022-09-07. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-09-07
- Form: D
- Accession: 0001905945-22-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Investors: 3
- Date of first sale: 2022-08-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-458186
Issuer
- Name: Rejuvitas, Inc.
- CIK: 0001905945
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: The Lasker Biomedical Research Building, New York, NY, 10032
- Phone: 516-448-6051
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Eric Heil | Director | BLUE BELL, PA |
| John Prufeta | Director | New York, NY |
| Andrea Spezzi | Director | New York, NY |
| Andrea Spezzi | Executive Officer | New York, NY |
| Joni Mancini | Executive Officer | Nissequogue, NY |
Other filings by this issuer (1)
More